Clinical Trial Update: Alefacept for Chronic Graft Versus Host Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting the completion of Phase 1 and Phase 2 studies of alefacept for resistant chronic graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Alefacept (Alefacept)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Resistant Chronic GVHD | Phase 1, Phase 2 | Status: COMPLETED